Form D · Pharmaceuticals

RENOVION, INC.

Chapel Hill, NC · CIK 0001670639

Offering snapshot reported Mar 28, 2023 · SEC filing

Reported sold
$15M
Offering amount: $15M
Investors reported
24
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 22, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 28, 2023Initial$15,017,305No comparison24SEC filing
May 29, 2020Amendment$8,099,999$3,146,954vs Feb 27, 202043SEC filing
Feb 27, 2020Initial$4,953,045No comparison8SEC filing
Feb 7, 2019Initial$492,196No comparison10SEC filing
May 15, 2018Initial$350,000No comparison12SEC filing
Jan 17, 2017Amendment$1,868,936$1,401,449vs Aug 30, 201613SEC filing
Aug 30, 2016Initial$467,487No comparison6SEC filing
Aug 30, 2016Amendment$467,487$0vs Aug 30, 20166SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-477139

Source: Form D, filed Mar 28, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas U. Barton Director
Jon Civitarese Director
Daniel W. Copeland Director, Executive
Joseph Davis Director
Richard Mattingly Director
R. Frederick Mccoy, Jr. Director
R. Frederick Mc Coy, Jr. Director
Robert Ryan Director
Derek Winstanly Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
900 Mlk Jr. Blvd Suite A
Chapel Hill, NC, 27514